Table 3.
Between-group minimal clinically important difference (MCID) of EQ-5D index scores for different comorbidities.
| Health Issue | n | EQ-5D Index Score | |
|---|---|---|---|
| Diff † | 95% CI | ||
| Comorbidities | |||
| No comorbidities | 264 | - | |
| Cardiovascular diseases | 121 | −0.09 * | −0.15; −0.02 |
| Musculoskeletal diseases | 61 | −0.14 * | −0.22; −0.06 |
| Digestive diseases | 60 | −0.01 | −0.09; 0.08 |
| Endocrine diseases | 51 | −0.13 * | −0.22; −0.04 |
| Kidney diseases | 26 | −0.13 * | −0.26; −0.01 |
| Ear, nose and throat diseases | 23 | 0.12 | −0.01; 0.25 |
| Number of comorbidities | |||
| 0 | 264 | - | |
| 1 | 166 | −0.10 * | −0.17; −0.02 |
| 2 | 61 | −0.07 | −0.18; 0.05 |
| ≥ 3 | 17 | −0.28 * | −0.48; −0.09 |
† Difference between respiratory patients with and without different chronic conditions. * p < 0.05.